导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 33.56% | 135/1050 |
| 近一周 | -4.59% | 1066/1104 |
| 近一月 | -4.74% | 743/1103 |
| 近一季 | -6.89% | 561/1092 |
| 近半年 | 17.67% | 195/1070 |
| 近一年 | 33.12% | 153/1018 |
| 近两年 | 77.26% | 327/926 |
| 近三年 | 24.31% | 455/834 |
| 成立以来 | 13.64% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.64% 159/1070 |
55.14% 198/1101 |
- - |
- - |
| 2025 | 20.04% 670/1065 |
-3.02% 955/1014 |
-2.86% 886/1038 |
36.91% 250/1050 |
-6.93% 795/1065 |
| 2024 | -15.53% 871/1011 |
-11.00% 796/960 |
-6.03% 694/983 |
9.74% 638/991 |
-7.96% 823/1011 |
| 2023 | -16.48% 579/952 |
12.22% 77/880 |
-8.85% 729/895 |
-9.62% 576/915 |
-9.66% 843/952 |
| 2022 | -25.66% 515/867 |
-21.75% 625/773 |
-3.11% 739/806 |
-8.25% 154/845 |
6.87% 139/867 |
| 2021 | 10.58% 238/740 |
3.75% 68/580 |
1.88% 517/659 |
-1.20% 237/704 |
5.90% 187/740 |
| 2020 | 31.28% 342/554 |
-4.90% 285/419 |
15.40% 345/466 |
13.93% 165/517 |
5.00% 440/554 |
| 2019 | - - |
- - |
- - |
-0.29% 341/390 |
7.43% 264/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 嘉实长青竞争优势股票C VS. 东吴新产业精选股票A(580008) |